You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Myeloid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

      Not yet recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • APN and medical management
      • +3 more
      • Avignon, Provence-Alpes-Côte d'Azur, France
        Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
      Oct 13, 2023

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

        Not yet recruiting
        • Tyrosine Kinase Inhibitors
        • Chronic Myeloid Leukemia
        • treatment of TKI in CML
        • Poitiers, France
          Chu Poitiers
        Feb 21, 2023

        Ponatinib in CML Patients in Chronic Phase

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Therapeutic drug monitoring
        • Molecular Response
        • Cagliari, Italy
        • +4 more
        Nov 3, 2023

        Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

        Recruiting
        • Chronic Myeloid Leukemia in Myeloid Blast Crisis
        • +3 more
        • based decitabine and olverembatinib（HQP1351)chemotherapy
        • Guanzhou, China
          Department of Hematology, Nanfang Hospital, Southern Medical Uni
        Dec 6, 2022

        Chronic Myeloid Leukemia (CML) Trial in France

        Recruiting
        • Chronic Myeloid Leukemia (CML)
          • Annecy, France
          • +11 more
          Jul 18, 2023

          CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

          Recruiting
          • CML
          • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
          • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
            FUNDALEU
          Jun 29, 2023

          Landscape and Real-life Treatment Outcomes in Hungary: Analysis

          Completed
          • Chronic Myeloid Leukaemia
          • Budapest, Hungary
            Pfizer
          Dec 15, 2022

          3L+ Therapies Among Chronic Myeloid Leukemia and Those With

          Completed
          • Chronic Myeloid Leukemia
            • East Hanover, New Jersey
              Novartis Investigative Site
            Nov 11, 2022

            Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

            Not yet recruiting
            • Chronic Myeloid Leukemia, BCR/ABL-Positive
              • Taipei, Taiwan
                National Taiwan University Hospital
              Jul 24, 2022

              CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

              Recruiting
              • CML, Chronic Phase
              • CML, Accelerated Phase
              • HS-10382(Part 1: Dose escalation)
              • HS-10382(Part 2: Dose expansion)
              • Wuhan, Hubei, China
                Union Hospital affiliated to Tongji Medical College of Huazhong
              Jan 12, 2023

              "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

              Not yet recruiting
              • Chronic Myeloid Leukemia, Chronic Phase
                • Sohag, Egypt
                  Sohag University Hospital
                Sep 14, 2022

                Condition Vasoregulation Function Endothelium in CML Getting TKI

                Recruiting
                • Chronic Myeloid Leukaemia
                • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
                • Moscow, Russian Federation
                • +1 more
                Jan 11, 2023

                Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

                Recruiting
                • Chronic Myeloid Leukemia, Chronic Phase
                • +3 more
                • Augusta, Georgia
                • +1 more
                Jul 14, 2022

                Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

                Completed
                • Leukemia
                • No Intervention
                • Cambridge, Massachusetts
                  Takeda
                Feb 28, 2023

                sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

                Completed
                • Chronic Myeloid Leukemia
                • ELISA kit
                • Tanta, Egypt
                  Tanta University
                May 18, 2022

                Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

                Recruiting
                • Chronic Myeloid Leukemia, Chronic Phase
                • Withdrawal;Drug
                • Imatinib withdrawal
                • +2 more
                • Brno, Czechia
                • +7 more
                Aug 24, 2022

                Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

                Recruiting
                • Olverembatinib
                • +2 more
                • Shenzhen, Guangdong, China
                  Shenzhen Second People's Hospital
                Jul 26, 2022

                According to Molecular Identification at Diagnosis

                Not yet recruiting
                • Chronic Myeloid Leukemia
                • Next Generation Sequencing (DNA and RNA)
                • (no location specified)
                Oct 28, 2022

                Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

                Recruiting
                • Chronic Myeloid Leukemia in Chronic Phase
                • Shenzhen, Guangdong, China
                  Shenzhen Second People's Hospital
                Jul 26, 2022

                Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

                Not yet recruiting
                • Acute Lymphoblastic Leukemia
                • +6 more
                • Miltenyi CliniMACS Prodigy ® system
                • (no location specified)
                Mar 23, 2023

                Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

                Recruiting
                • Chronic Phase Chronic Myelogenous Leukemia
                • +3 more
                • Houston, Texas
                  M D Anderson Cancer Center
                Aug 11, 2022